Conference Call Year-end Report 2018

All interested parties are invited to participate in a telephone conference, which will include a presentation of the Year-end Report.

When: 09:00 a.m. CET Thursday 14 February 2019. Listen to the presentation:
https://financialhearings.com/event/11461

To participate in the telephone conference, please use the dial in details shown below:
SE: +46856642692
UK: +443333009266
US: +18338230590

CEO Per Norlén comments on the Nobel Prize in Physiology or Medicine 2018

On Monday October 1st the Nobel Prize in Physiology or Medicine 2018 was awarded jointly to James P. Allison and Tasuku Honjo for their discovery of cancer therapy by inhibition of negative immune regulation – a discovery the Nobel Assembly at Karolinska Institutet said has “revolutionized cancer treatment and has fundamentally changed the way we view how cancer can be managed”.

Read more

RODMAN & RENSHAW INVESTMENT CONFERENCE, NEW YORK

Meet the future of antibody-based immuno-oncology drugs.

CEO Per Norlén is presenting the company at the 20th Annual Rodman & Renshaw Global Investment Conference in New York on September 6, at 3.25 pm EDT (9:25 pm CEST).

The presentation can be followed live and afterwards at http://wsw.com/webcast/rrshq28/atorx/.

Alligator Bioscience Capital Markets Day in Stockholm on May 29, 2018

Meet the future of antibody-based immuno-oncology drugs.

Listen to the presentations here.

Frontier

A magazine about Alligator Bioscience and immuno-oncology